ACT TO IMPROVE LIFE PROVEPHARM
LIVE

Serial Number

79417239

Owner

PROVEPHARM LIFE SOLUTIONS

Attorney

Kaitlyn M. Garvin

Filing Date

Nov 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ACT TO IMPROVE LIFE PROVEPHARM Trademark

Serial Number: 79417239 • Registration: 7989149

ACT TO IMPROVE LIFE PROVEPHARM is a trademark filed by PROVEPHARM LIFE SOLUTIONS on November 8, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PROVEPHARM LIFE SOLUTIONS (19 trademarks)

22, RUE MARC DONADILLE
MARSEILLE 13013 , FR

Entity Type: 33

Trademark Details

Filing Date

November 8, 2024

Registration Date

October 21, 2025

Published for Opposition

September 2, 2025

Goods & Services

Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additives, namely, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agents, namely, enzyme stabilizers for vitamins

Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leg, hoof, ear, nose and throat for animals; vitamins for animals; medicated foams, oils, lotions, creams, balms, ointments, gels and milks for the treatment of skin for pharmaceutical, medical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical products, namely, surgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceutical, namely, surgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutions, namely, surgical dyes for medical use; indigo carmine, namely, surgical dyes for medical use; indigo cumin solutions, namely, surgical dyes for medical use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 6, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 20, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 19, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 1, 2026 FICS
FINAL DISPOSITION PROCESSED
May 1, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 21, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2025 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2025 RFNT
ASSIGNED TO LIE
Jun 23, 2025 ALIE
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 14, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR